Normal preoperative white blood cell count is predictive of outcomes for endovascular procedures

Journal of Vascular Surgery

Volumn 54, Issue 5, 2011, Pages 1395-1403.e2

  Amaranto, Daniel J ^a   Wang, Edward C ^a   Eskandari, Mark K ^a   Morasch, Mark D ^a   Rodriguez, Heron E ^a   Pearce, William H ^a   Kibbe, Melina R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; AGED; AMPUTATION; AORTA ANEURYSM; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; DEATH; ENDOVASCULAR ANEURYSM REPAIR; ENDOVASCULAR SURGERY; FEMALE; HEART INFARCTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 80054856501     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.04.063     Document Type: Article

References (39)

1. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Col Cardiol 2004;44:1945-56.
2. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
3. Albert A, Beller C, Walter J, Arnrich B, Rosendahl U, Priss H, et al. Preoperative high leukocyte count: a novel risk factor for stroke after cardiac surgery. An Thorac Surg 2003;75:1550-7.
4. Bhatt DL, Chew DP, Lincoff AM, Simoons ML, Harrington RA, Ommen SR, et al. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol 2003;92:136-40.
5. Dacey LJ, DeSimone J, Braxton JH, Leavitt BJ, Lahey SJ, Klemperer JD, et al. Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. Ann Thorac Surg 2003;76: 760-4.
6. Gurm HS, Bhatt DL, Gupta R, Ellis SG, Topol EJ, Lauer MS, et al. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J 2003;146:692-8.
7. Newall N, Grayson AD, Oo AY, Palmer ND, Dihmis WC, Rashid A, et al. Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1-year mortality after coronary artery bypass crafting. Ann Thorac Surg 2006;81:583-9.
8. Gu YJ, deVries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thoracic Cardiovasc Surg 1996;112:494-500.
9. Toor IS, Jaumdally RJ, Moss MS, Babu SB. Preprocedural neutrophil count predicts outcome in patients with advanced peripheral vascular disease undergoing percutaneous transluminal angioplasty. J Vasc Surg 2008;48:1504-8.
10. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. Disorders of granulocytes and monocytes. Harrison's principles of internal medicine. 16th ed. New York, NY: McGraw-Hill Professional; 2005. p. 349.
11. Complete Blood Count (CBC) with 5-Part Differential; National Health and Nutrition Examination Survey (NHANES). 2003-2004 Data Documentation, Codebook, and Frequencies. 2010. Available at: http://www.cdc.gov/nchs/nhanes/nhanes2003- 2004/L25-C.htm. Accessed February 1, 2010.
12. Haugen S, Casserly IP, Regensteiner JG, Hiatt WR. Risk assessment in the patient with established peripheral arterial disease. Vasc Med 2007; 12:343-50.
13. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-6.
14. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
15. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000;343:1179-82.
16. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-26.
17. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL, et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006;97:993-6.
18. Jurewitz DL, Pessegueiro A, Zimmer R, Bhatia R, Tobis J, Lee MS, et al. Blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stents. J Invasive Cardiol 2009;5:202-6.
19. Kruk M, Karcz M, Przyłuski J, Bekta P, Kepka C, Kalińczuk Ł, et al. White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry) (White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention [ANIN Myocardial Infarction Registry]). Int J Cardiol 2007;116:376-82.
20. Upadhya B, Applegate RJ, Sane DC, Deliargyris EN, Kutcher MA, Gandhi SK, et al. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 2005;96:515-8.
21. Prasad A, Stone GW, Stuckey TD, Costantini CO, Mehran R, Garcia E, et al. Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. Am J Cardiol 2007;99:1067-71.
22. De Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the normative aging study. J Clin Epidiemol 1990;43:153-7.
23. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:1102-8.
24. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-8.
25. Grimm RH Jr, Neaton JD, Ludwig W, Multiple Risk Factor Intervention Trial Research Group. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985; 254:1932-7.
26. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
27. Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med 2007;262:678-89.
28. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003;107:1486-91.
29. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The caerphilly and speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
30. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279: 1477-82.
31. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000;102:2329-34.
32. Grzybowski R, Welch R, Parsons L, Ndumele C, Chen E, Zalenski R, et al. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the national registry of myocardial infarction. Acad Emerg Med 2004;11:1049-60.
33. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Col Cardiol 1996;28:345-53.
34. Serrano MD, Ramires MFJA, Venturinelli BS, Arie MD, D'Amico MD, Zweier MD, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: evidence of inflammatory responses in coronary angioplasty. J Am Col Cardiol 1997;29:1276-83.
35. Arnaoutoglou E, Papas N, Milionis H, Kouvelos G, Koulouras V, Matsagkas MI, et al. Post-implantation syndrome after endovascular repair of aortic aneurysms: need for postdischarge surveillance. Interact Cardiovasc Thorac Surg 2010;11:449-54.
36. Prytherch DR, Ridler B, Ashley S. Risk-adjusted predictive models of mortality after index arterial operations using a minimal data set. Br J Surg 2005;92:714-8.
37. Tang TY, Prytherch DR, Walsh SR, Athanassoglou V, Seppi V, Sadat U, et al. The development of a VBHOM-based outcome model for lower limb amputation performed for critical ischaemia. Eur J Vasc Endovasc Surg 2009;37:62-6.
38. Tang T, Walsh S, Prytherch D, Lees T, Varty K, Boyle J, et al. A data economic model for predicting the outcome after open abdominal aortic aneurysm surgery. Br J Surg 2007;94:717-21.
39. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987;257: 2318-24.